Clinical Trials Logo

FED clinical trials

View clinical trials related to FED.

Filter by:

NCT ID: NCT05995119 Completed - Healthy Volunteers Clinical Trials

Comparative Bioavailability Study of TAH3311 5 mg Oral Dissolving Film vs ELIQUIS® 5 mg Tablet in Healthy Volunteers

Start date: December 5, 2022
Phase: Early Phase 1
Study type: Interventional

The goal of this clinical trial is to evaluate the pharmacokinetic profiles and bioequivalence, and to determine the safety and tolerability of the TAH3311 Oral Dissolving Film (ODF) 5mg compared with ELIQUIS® (Apixaban) 5mg Oral Tablet, after single dose under fasted and fed conditions in healthy volunteers.

NCT ID: NCT05837572 Recruiting - Fasting Clinical Trials

Development of the Leeds Food Preference Questionnaire in Spanish

ES-LFPQ
Start date: March 7, 2023
Phase: N/A
Study type: Interventional

The Leeds Food Preference Questionnaire (LFPQ) is a computer-based task used to measure reward responses and preferences for images of food. The present study aims to develop a Spanish version of the LFPQ (ES-LFPQ) by examining its validity and repeatability under fasted and fed states.

NCT ID: NCT03390881 Completed - Fasting Clinical Trials

Use of Breath Acetone aa a Marker of Energy Balance

ACEX
Start date: November 2016
Phase: N/A
Study type: Interventional

This study aims at assessing whether breath acetone concentration is a good bio-marker of instantaneous energy balance in healthy subjects.

NCT ID: NCT01884909 Completed - Fed Clinical Trials

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions

Start date: April 2013
Phase: Phase 1
Study type: Interventional

This is an open Label, randomized, two-period, two-treatment, two-sequence, crossover, balanced, single dose pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in healthy adult human subjects.

NCT ID: NCT01827878 Completed - Fed Clinical Trials

Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions

Start date: October 2012
Phase: Phase 1
Study type: Interventional

This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, cross over pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult, human subjects.

NCT ID: NCT01744873 Completed - Fed Clinical Trials

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition

Start date: August 2012
Phase: Phase 1
Study type: Interventional

This is a randomized, open Label, balanced, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult human subjects.

NCT ID: NCT01735383 Completed - Fed Clinical Trials

Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition

Start date: May 2012
Phase: Phase 1
Study type: Interventional

This is a open Label, balanced, randomized, single dose, two-treatment, two-sequence, two-period, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in healthy, adult human subjects.

NCT ID: NCT01735344 Completed - Fed Clinical Trials

Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

Start date: June 2012
Phase: Phase 1
Study type: Interventional

This is a randomized, balanced, open Label, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult, male and female human subjects.

NCT ID: NCT01722110 Completed - Fed Clinical Trials

Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition

Start date: April 2012
Phase: Phase 1
Study type: Interventional

This is a randomized, balanced, open Label, two-treatment, two-period, two-sequence, single dose, crossover pivotal study. The purpose of this study is to assess the bioequivalence between Test Product and the corresponding Reference Product under fed condition in normal, healthy, adult, male and female human subjects.

NCT ID: NCT01721187 Completed - Fasting Clinical Trials

Satiety Effects on the Neural Valuation of Food

Start date: October 2012
Phase: N/A
Study type: Observational

Using fMRI, this study will explore the neural correlates of satiety when individuals make decisions about food. The investigators will also examine individual differences in satiety effects.